Blog

The clinical evidence is real. The valuations are not. Compass Pathways: $560 million market cap, zero revenue. MindMed: up to $2 billion, zero revenue. Even Ozempic […]

This article originally appeared in High Times’ 50th Anniversary print issue. It has been updated to reflect the Czech Republic’s January 1, 2026 cannabis legalization taking […]

Sweetlife is turning New York’s old-school cannabis relationship into something licensed, polished, and built around being taken care of. Anyone who has lived in New York […]

Nearly 985,000 cannabis club identity documents were reportedly exposed through public URLs linked to Cannabis Club Systems and PuffPal, raising serious questions about how the industry […]

Before pre-rolls were everywhere and convenience became a selling point, the blunt already had a seat in the session. It was in the studio, in the […]

New Jersey’s cannabis market is not in its baby teeth era anymore. The state has flower brands with loyal followings, pre-roll makers swinging hard, edible companies […]

In the early ’90s, the SoCal trio of Bradley Nowell, Eric Wilson and Bud Gaugh pioneered a mashup of ska, punk, reggae and hip-hop that took […]

Award-winning cannabis journalist and best-selling author David Downs highlights the hottest flowers blazing up the charts in legal U.S. states for the start of summer. It’s […]

Zac Efron is building an ambitious off-grid home in Australia that will incorporate hemp across everything from walls and insulation to mattresses, textiles, and interior components. […]